Clarus Wealth Advisors’s Bio-Techne TECH Stock Holding History

Clarus Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,572	Closed	-$569K	–	133
2021 Q1	$569K	Hold	5,572	–	–	0.36%	57
2020 Q4	$466K	Hold	5,572	–	–	0.31%	60
2020 Q3	$357K	Hold	5,572	–	–	0.28%	73
2020 Q2	$372K	Hold	5,572	–	–	0.31%	69
2020 Q1	$260K	Hold	5,572	–	–	0.26%	96
2019 Q4	$302K	Hold	5,572	–	–	0.2%	108
2019 Q3	$273K	Buy	+5,572	New	+$279K	0.2%	106

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Clarus Wealth Advisors's TECH Position: Q2 2021 in Review

Clarus Wealth Advisors sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 5,572 shares — an estimated $569K sold.

Clarus Wealth Advisors first reported a position in TECH in Q3 2019 and held it in 7 quarters. The position peaked at $569K in Q1 2021. 513 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

Clarus Wealth Advisors reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
Clarus Wealth Advisors sold 5,572 Bio-Techne shares in Q2 2021, an estimated $569K.
Clarus Wealth Advisors first reported a position in Bio-Techne in Q3 2019 and held it in 7 quarters.
Clarus Wealth Advisors's Bio-Techne position peaked at $569K in Q1 2021.
513 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Clarus Wealth Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.